Neo Ivy Capital Management Raises Position in Sotera Health (NASDAQ:SHC)

Neo Ivy Capital Management raised its stake in shares of Sotera Health (NASDAQ:SHC - Free Report) by 144.7% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 105,546 shares of the company's stock after purchasing an additional 62,420 shares during the period. Neo Ivy Capital Management's holdings in Sotera Health were worth $1,443,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of SHC. Blue Trust Inc. grew its holdings in Sotera Health by 164.3% during the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock valued at $25,000 after purchasing an additional 1,140 shares during the period. Quarry LP purchased a new position in shares of Sotera Health in the fourth quarter valued at about $28,000. Tower Research Capital LLC TRC lifted its position in shares of Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock valued at $82,000 after acquiring an additional 1,640 shares in the last quarter. Sterling Capital Management LLC lifted its position in shares of Sotera Health by 58.5% in the fourth quarter. Sterling Capital Management LLC now owns 9,029 shares of the company's stock valued at $124,000 after acquiring an additional 3,331 shares in the last quarter. Finally, PNC Financial Services Group Inc. lifted its position in shares of Sotera Health by 39.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company's stock valued at $127,000 after acquiring an additional 2,627 shares in the last quarter. Institutional investors own 91.03% of the company's stock.

Sotera Health Price Performance

Shares of NASDAQ:SHC traded up $0.27 during mid-day trading on Tuesday, reaching $12.43. The stock had a trading volume of 613,508 shares, compared to its average volume of 1,203,156. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The company has a market cap of $3.53 billion, a P/E ratio of 49.72 and a beta of 1.88. Sotera Health has a 1 year low of $9.53 and a 1 year high of $17.08. The business's 50 day moving average price is $11.65 and its 200 day moving average price is $12.68.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its earnings results on Thursday, May 1st. The company reported $0.14 EPS for the quarter, topping analysts' consensus estimates of $0.12 by $0.02. The company had revenue of $254.52 million for the quarter, compared to the consensus estimate of $245.56 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The firm's revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.13 earnings per share. Research analysts expect that Sotera Health will post 0.61 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently commented on SHC shares. The Goldman Sachs Group upgraded Sotera Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $14.00 to $17.00 in a research report on Monday, May 5th. Piper Sandler lowered their price objective on Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 23rd. Finally, Barclays lowered their price objective on Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, Sotera Health presently has an average rating of "Moderate Buy" and a consensus target price of $15.80.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.